Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Anchisi

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Revue Medicale Suisse|May 17, 2018
[Oncology trajectories of elderly patients in a palliative situation : « The long and winding road »]Annick Anchisi, Rose-Anna Foley, Claire Ansermet, et al.
Revue Medicale Suisse|July 5, 2017
[Diarrhea caused by systemic anti-cancer treatments]Irma Dischl-Antonioni, Grégoire Berthod, Philippe Hiroz, et al.
Critical Reviews in Oncology/Hematology|April 10, 2026
Past, Present, and Future Perspectives in Estrogen-Receptor-Low Breast CancerDre Marie-Gabrielle Courtès, Dre Cristina Florea, Sandro Anchisi
Revue Medicale Suisse|May 29, 2020
[Immunotherapy with immune checkpoint inhibitor and skin toxicity]Pierre-François Simand, Grégoire Berthod, Laurent Parmentier, et al.
Social Science & Medicine (1982)|October 20, 2019
Rising to the medication's requirements: The experience of elderly cancer patients receiving palliative chemotherapy in the elective oncogeriatrics fieldRose-Anna Foley, Lucie Lechevalier Hurard, Annick Anchisi, et al.
Revue Medicale Suisse|May 16, 2019
[Immunotherapy with immune checkpoint inhibitors and hepatitis]Nathalie Baudoux, Grégoire Berthod, Frank Bally, et al.
Bulletin Du Cancer|April 22, 2006
[Accepting chemotherapy at the age of 70 and over: between autonomy and ageing]Annick Anchisi, Sandro Anchisi, Valérie Hugentobler, et al.
Revue Medicale Suisse|May 17, 2023
[PARP inhibitors - A better selection of patients]Marc Senglet, Grégoire Berthod, Marie-Gabrielle Courtes, et al.
Cancers|July 29, 2025
Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with ChemotherapyDaniele Frisone, Melinda Charrier, Grégoire Berthod, et al.
Oncology|June 13, 2018
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT DataOlalla Santa Cruz, Pelagia Tsoutsou, Cyril Castella, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Revue Medicale Suisse|May 17, 2018
[Oncology trajectories of elderly patients in a palliative situation : « The long and winding road »]Annick Anchisi, Rose-Anna Foley, Claire Ansermet, et al.
Revue Medicale Suisse|July 5, 2017
[Diarrhea caused by systemic anti-cancer treatments]Irma Dischl-Antonioni, Grégoire Berthod, Philippe Hiroz, et al.
Critical Reviews in Oncology/Hematology|April 10, 2026
Past, Present, and Future Perspectives in Estrogen-Receptor-Low Breast CancerDre Marie-Gabrielle Courtès, Dre Cristina Florea, Sandro Anchisi
Revue Medicale Suisse|May 29, 2020
[Immunotherapy with immune checkpoint inhibitor and skin toxicity]Pierre-François Simand, Grégoire Berthod, Laurent Parmentier, et al.
Social Science & Medicine (1982)|October 20, 2019
Rising to the medication's requirements: The experience of elderly cancer patients receiving palliative chemotherapy in the elective oncogeriatrics fieldRose-Anna Foley, Lucie Lechevalier Hurard, Annick Anchisi, et al.
Revue Medicale Suisse|May 16, 2019
[Immunotherapy with immune checkpoint inhibitors and hepatitis]Nathalie Baudoux, Grégoire Berthod, Frank Bally, et al.
Bulletin Du Cancer|April 22, 2006
[Accepting chemotherapy at the age of 70 and over: between autonomy and ageing]Annick Anchisi, Sandro Anchisi, Valérie Hugentobler, et al.
Revue Medicale Suisse|May 17, 2023
[PARP inhibitors - A better selection of patients]Marc Senglet, Grégoire Berthod, Marie-Gabrielle Courtes, et al.
Cancers|July 29, 2025
Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with ChemotherapyDaniele Frisone, Melinda Charrier, Grégoire Berthod, et al.
Oncology|June 13, 2018
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT DataOlalla Santa Cruz, Pelagia Tsoutsou, Cyril Castella, et al.
Pageof 4